Biological Assets

A biological asset is any living plant or animal held by a business for agricultural activity, measured at fair value less estimated costs to sell under IAS 41. Unlike ordinary fixed assets that use historical cost, biological assets are revalued every reporting period, with unrealised gains and losses flowing directly to the income statement rather than equity.

Why biological assets demand fair-value accounting

Standard accounting assumes assets remain static until sold or consumed. But a herd of cattle, a forest plantation, or a vineyard generates value passively—through growth and maturation—before any sale occurs. A dairy cow purchased at market price will be worth more in six months simply because it has matured and proven its productivity. Treating it at cost would freeze an economically false value onto the balance sheet.

IAS 41 resolves this by requiring fair-value revaluation every reporting period. The rationale is faithful representation: the assets’ real economic worth—what they could fetch on an active market—should reflect current conditions. A mature wine vintage in a cellar is worth far more than its historical harvest cost; a fattened beef steer is worth more than a lean calf purchased months earlier.

Unrealised gains from growth do not merely sit in an equity reserve (as revaluation surplus does for buildings). They flow to the income statement as realised profit. A farmer can thus report a profitable year even without selling a single animal, purely from the mark-to-market appreciation of the breeding herd—a reality foreign to US GAAP, where such gains would not be recognised until harvest or sale.

How biological assets appear on the balance sheet

Biological assets are classified as current assets or non-current assets depending on the expected holding period. A wheat crop planted in spring and harvested in autumn is typically current. A breeding sow, expected to produce litters over several years, is non-current.

On the balance sheet, they sit separately from inventory. This distinction matters: inventory (grain in storage, canned fruit) is valued at the lower of cost or net realisable value under standard rules. Biological assets (the standing crop, the live animal) are marked to fair value. The moment wheat is harvested, it shifts from a biological asset to agricultural produce—and from fair-value measurement to cost-based accounting.

Consider a poultry farm:

• Biological asset: 10,000 live laying hens, fair value $8 per bird = $80,000 on the balance sheet
• Agricultural produce: 500 eggs in cold storage, inventoried at cost = separate line item

When the hens age and their lay rates decline, fair value drops to $6 per bird. A $20,000 loss hits the income statement—not a provision or write-down, but a recognised loss in the year it occurs.

Measuring fair value in practice

IFRS prefers active market prices. If there is a transparent market for dairy cows, breeding sows, or sheep, entities use quoted prices less estimated selling costs (transport, commission, weight loss). But many agricultural assets lack such markets. A rare heritage vineyard, a uniquely adapted breeding flock, or genetically modified seed stock has no published quotation.

In these cases, entities use level 2 or level 3 valuations: discounted cash flows (future calf sales from a breeding cow), comparable sales of similar animals, or expert appraisals by veterinarians and agronomists. This discretion creates a risk: management might inflate fair values to boost reported profit, and auditors must challenge dubious inputs.

Seasoned analysts often adjust back these unrealised biological gains when comparing farm profitability year to year, treating them as non-operational noise. A bumper-crop gain in one season followed by a drought loss in the next can obscure underlying cash economics.

Agricultural produce versus biological assets

The moment a biological asset is harvested, cut, or slaughtered, it becomes agricultural produce—subject to immediate fair-value recognition on the date of harvest, then expensed or inventoried under normal cost accounting rules.

Example:

• June: Standing timber (biological asset) revalued to $500,000 (unrealised gain: +$50,000 to profit)
• July: Trees felled and logs stacked; timber is now agricultural produce at fair value $480,000 at date of harvest
• September: Logs sold to mill; sale price $470,000; loss on agricultural produce: $10,000

The system thus captures value creation at three decision points: growth (mark-to-market of the living asset), harvest (fair value at that date), and sale (actual realisation).

Why IAS 41 matters to analysts and investors

For companies with significant agricultural operations—agribusiness conglomerates, plantation companies, wine producers—IAS 41 can swing reported profit dramatically. A bumper coffee harvest or a strong genetic gain in livestock can create a multi-million-dollar non-cash profit, inflating earnings per share and return on equity without a corresponding increase in cash flow.

Conversely, a pest outbreak or disease outbreak can trigger massive unrealised losses that depress reported profit but might be temporary. Sophisticated analysts build detailed harvest-cycle models to strip out these biological gains and losses, focusing on cash realised from actual harvests and sales.

Smaller farmers or family agricultural businesses often use IFRS except IAS 41, opting instead for cost-based accounting. The exemption reflects the practical burden of obtaining annual fair-value appraisals for thousands of small livestock or scattered orchards. Multinational agricultural corporations, by contrast, embrace IAS 41 because fair-value transparency is expected by equity investors and credit markets.

See also